National Cancer Institute (NCI)

group of people in a circle looking down at the camera

27Jul2022

Bizzell Supports Development of Comprehensive Report Addressing Smoking Cessation Treatment within Cancer Care Settings

July 27, 2022 (New Carrollton, MD) — The Bizzell Group is proud to provide direct support to the National Cancer Institute, part of the National Institutes of Health, in the development of Tobacco Control Monograph 23—Treating Smoking in Cancer Patients: An Essential Component of Cancer Care. Released on June 29^th, the monograph expands upon prior research from the 2014 and 2020 Surgeon General’s reports to inform clinicians and their patients with cancer about the science and practice of quitting smoking. The monograph also builds on recent findings from the National Cancer Institute’s (NCI) Moonshot℠ Cancer Center Cessation Initiative (C3I) program. “The monograph provides evidence that clinicians, public health practitioners, researchers, and patients with cancer can use to help influence real-world change in the treatment of patients with cancer who smoke. I am grateful for the opportunity to collaborate with NCI and subject matter experts to produce a rigorous volume on such an important topic,” said Jenny Twesten, Managing Director of Health Communications & Research at Bizzell, who oversaw the editorial and publication support for the monograph.

Smoking cessation treatment is rarely addressed in cancer care settings, yet the research summarized in the monograph demonstrates that quitting smoking is among the most effective treatment options for improving the likelihood of survival, quality of life, and overall health of people with cancer who smoke. The monograph also provides clinicians with evidence-based strategies and treatment options they can implement to better address smoking with cancer patients.
“Monograph 23 leverages prior academic research to demonstrate that addressing smoking cessation within the cancer treatment protocol yields tremendous benefits. I am greatly appreciative of the rigorous development process led by the Federal staff, Scientific Editorial Committee, peer-review experts, and the Bizzell team” said Anton C. Bizzell, M.D., President and CEO of Bizzell.

To read the full monograph, please visit: https://cancercontrol.cancer.gov/brp/tcrb/monographs/monograph-23

About Bizzell

Established in 2010, Bizzell US is U.S. Small Business Administration (SBA) HUBZone certified strategy, consulting, and technology firm with a mission to improve lives and accelerate change. Bizzell US develops innovative solutions to some of the most critical issues of our time such as health care services equity, global health, workforce innovation and other urgent needs facing the world. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown into a thriving firm headquartered in New Carrollton, Maryland with staff and offices in various regions around the country including California, Colorado, Oklahoma, and Georgia, and globally in Africa, Asia, and Central America. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges. Learn more at BizzellUS.com.

13Nov2020

Bizzell PD Co-Authors Manuscript in NTR

Jenny Twesten, MPH, Project Director of the National Cancer Institute, Tobacco Control Research Branch contract, co-authored a manuscript in the November issue of Nicotine & Tobacco Research (NTR) that was selected as an Editor’s Choice submission. The manuscript details the challenges of measuring cigarette smoking risk perceptions among adult smokers and non-smokers on questionnaires and opportunities for improved measurement based on current scientific evidence. The co-authors provide ten suggestions for researchers and survey developers to consider when assessing cigarette risk perceptions to improve how smoking risk perceptions may influence cigarette smoking behaviors.

Jenny is a public health communicator with more than seven years of experience providing clients with innovative solutions to disseminating research, synthesizing the state-of-the-science, and improving self-report assessments. She contributed to the production of two monographs, managed an extramural research portfolio, and led the early adoption of podcasts to disseminate research. As a Project Director at Bizzell, she provides research and communications guidance on a portfolio of tobacco and cancer-related projects, including co-authoring three tobacco control manuscripts and overseeing the implementation of two digital media campaigns. Her research interests are cancer prevention, early detection and survivorship, modifiable health behaviors such as tobacco use, and risk perception. She holds a Master of Public Health from George Washington University.

Nicotine & Tobacco Research (NTR) is one of the world’s few peer-reviewed journals devoted exclusively to the study of nicotine and tobacco. It aims to provide a forum for empirical findings, critical reviews, and conceptual papers on the many aspects of nicotine and tobacco, including research from the biobehavioral, neurobiological, molecular biologic, epidemiological, prevention, and treatment arenas.

Read Article: https://academic.oup.com/ntr/article/22/11/1937/5688704

A closeup phot of a wooden table with a cigarette with the words, "the last one" written on the side.

31May2018

World No Tobacco Day

Every year on May 31st, The World Health Organization (WHO) and partners mark World No Tobacco Day (WNTD). World No Tobacco Day (WNTD) highlights the health and other risks associated with tobacco use and advocate for effective policies to reduce tobacco consumption. WNTD focuses on the impact tobacco use has on the cardiovascular health and how tobacco use is an important risk factor for the development of coronary heart disease, stroke, and peripheral vascular disease.

Although Tobacco is considered a legal drug, the effects and complications related to tobacco use kill many of its users when used as intended by manufacturers. WHO has estimated that the use of tobacco is responsible for the death of about six million people across the world yearly. WHO’s new Global Report on Trends in Prevalence of Tobacco Smoking 2000-2025 report shows that 27% of people worldwide smoked in 2000, compared to 20% in 2016.

For tobacco users that are interested in quitting and living a healthier lifestyle, there are many resources available to help develop a solid “quit plan” that provides ways to stay focused, confident, and motivated throughout the journey. Smokefree.gov has 5 steps that can help smokers handle quit day, which is a smoker’s first day without cigarettes.

1. Make a Quit Plan

Having a quit plan can make quitting much easier. You can build your plan or find a program that works for you. Visit Create My Quit Plan for assistance.

2. Stay Busy

Staying busy is a great way to stay smoke-free. Being busy will help keep your mind off smoking and distract you from cravings. Here is a list of activity ideas that could help distract you:

Exercise
Chew gum or hard candy
Drink lots of water
Go to a movie
Spend time with non-smoking friends and family
Go to dinner with non-smoking friends and family

3. Avoid Smoking Triggers

Triggers are people, places, things, and situations that set off your urge to smoke. Here are some ways to avoid common smoking triggers:

Throw away your cigarettes, lighters, and ashtrays
Avoid caffeine and replace with water instead
Change your routine to avoid the things you might associate with smoking

4. Stay Positive

Try not to put too much pressure on yourself about quitting. Take things one day at a time and reward yourself for small milestones.

5. Ask for Help

You don’t have to do this alone. Ask for support from your family, friends, or a professional. They can help you get through the rough spots.

28Mar2018

17th World Conference on Tobacco or Health

Project Director Jenny Twesten traveled to Cape Town, South Africa to represent the National Cancer Institute’s Tobacco Control Research Branch at WCTOH held March 6-9, 2018. This international conference drew participants from around the world, with a particularly strong presence from those across Africa, an area where prevalence of cigarette smoking is on the rise and expected to continue to do so without strong tobacco control interventions. The Bizzell Group (Bizzell) supported meeting logistics for a pre-conference workshop entitled “Research to Inform the Development and Implementation of Tobacco Control Policies and Intervention” that was attended by at least 53 people from 23 different countries.

Bizzell also coordinated the NCI presence in the exhibit hall in collaboration with the Centers for Disease Control and Prevention, which nearly ran out of materials within 4 hours of the exhibit hall opening. In addition to attending sessions on electronic nicotine delivery systems (ENDS), economic and social costs of tobacco among women, tools for monitoring tobacco use, and ending the tobacco epidemic, Jenny presented on the Africa literature review that she and Katie Cleffi have been working on with NCI and met with various organizations and experts to discuss collaboration opportunities with NCI. The abstract presented has been published in a special supplement of Tobacco Induced Diseases. She will be presenting along with the other NCI delegates at an upcoming seminar on April 17 hosted by the NCI Center for Global Health to share insights from their WCTOH attendance.

Tag Archives: National Cancer Institute (NCI)